LexDanaLexDanabeta
Inventor

Rene Wyler

Inventor
Zurich, CH

Overview

39→
Patents
1997–2012
Patent span
Human necessities
Primary field (CPC A)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
8,288,541'Piperazine amide derivatives'20127,456,210'Benzyloxy derivatives'20087,253,318'Benzyloxy derivatives as MAOB inhibitors'20077,235,581'4-pyrrolidino-phenyl-benzyl ether derivatives'20077,173,023'Bicyclic compounds'20077,151,111'4-pyrrolidino-phenyl-benzyl ether derivatives'20067,122,562'4-pyrrolidino-phenyl-benzyl ether derivatives'20067,087,612'3H-quinazolin-4-one derivatives as MAO-B inhibitors'20067,053,245'N-acylamino benzyl ether derivatives'20067,037,935'4-Pyrrolidino-phenyl-benzyl ether derivatives'20067,034,044'Conjugated aromatic compounds with a pyridine substituent'20066,951,884'Fluorobenzamides and uses thereof'20056,951,875'Conjugated aromatic compounds with a pyridine substituent'20056,903,095'Phthalimido derivatives and a process for their preparation'20056,900,354'3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives'20056,846,832'2,3-dihydro-isoindol-1-one derivatives'20056,831,087'Pyridine substituted isoquinoline derivatives'20046,818,774'Isoquinoline derivatives'20046,762,320'N-acylamino benzyl ether derivatives'20046,683,097'Imidazole derivatives'20046,667,335'Imidazole derivatives'20036,667,327'Pyridine amido derivatives'20036,660,736'Phthalimido derivatives and a process for their preparation'20036,610,723'Imidazole derivatives'20036,451,819'Heterocyclic compounds useful as NMDA receptor selective subtype blockers'20026,440,995'Quinolin-4-yl derivatives'20026,432,985'Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists'20026,407,235'Prodrug acid esters of 2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonylphenol'20026,359,138'4-hydroxy-piperidine derivatives'20026,339,093'Isoquinoline derivatives'20026,310,213'Ethanesulfonyl-piperidine derivatives'20016,265,426'Triazole derivatives'20016,184,236'Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative'20016,153,624'Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders'20006,071,929'Octahydro phenanthridine derivatives useful as NMDA-R receptor subtype blockers'20006,015,824'Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders'20005,952,344'Tetrahydroisoquinoline derivatives'19995,889,026'4-hydroxy-piperodine derivatives'19995,688,803'Tricyclic dicarbonyl derivatives'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2012Patents assigned to HOFFMANN LA ROCHE (37)· patent assignee history
1997–2012Based in Zurich, CH· patent location history
2000Patents assigned to HOFFMAN LAROCHE INC (1)· patent assignee history
2002–2006Based in Zuerich, CH· patent location history
2002Based in Zrich, CH· patent location history
2007Patents assigned to HOFFMANN-LA ROCHE INC. (1)· patent assignee history
2012Patents assigned to DEHMLOW HENRIETTA (1)· patent assignee history
2012Patents assigned to KUHN BERND (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE371997–2012
DEHMLOW HENRIETTA12012
HOFFMAN LAROCHE INC12000
HOFFMANN-LA ROCHE INC.12007
KUHN BERND12012
Locations
LocationPatentsSpan
Zurich, CH341997–2012
Zuerich, CH42002–2006
Zrich, CH12002